AI-generated summary
The authors compared 38 patients after mesiodens surgery, with 18 receiving diode laser photobiomodulation (808 nm) and 20 serving as controls, measuring salivary sIgA and lysozyme levels before and after treatment. They report that sIgA decreased significantly in the control group but not in the laser group, and that lysozyme trends mirrored sIgA. The authors conclude that 3D imaging combined with laser therapy could support healing and reduce inflammation.
- Participants
- 38
- Who or what was studied
- Patients undergoing mesiodens surgery (18 laser-treated, 20 control)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract reports a small sample and does not clearly describe the inferential basis for the healing and inflammation conclusions, and the initial lysozyme values moved in opposite directions between groups.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Laser, Photobiomodulation, Placebo-controlled, Control group, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.